Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly P Dunsmore

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2012
Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupKimberly P Dunsmore, Meenakshi Devidas, Stephen B Linda, et al.
Biomarker Research|August 31, 2018
Dysregulated transcriptional networks in <i>KMT2A-</i> and <i>MLLT10</i>-rearranged T-ALLHuining Kang, Nitesh D Sharma, Christian K Nickl, et al.
Science Translational Medicine|May 18, 2012
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemiaDavid Wu, Anna Sherwood, Jonathan R Fromm, et al.
Blood Advances|July 23, 2021
Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphomaXinjie Xu, Christian N Paxton, Robert J Hayashi, et al.
JAMA Network Open|December 29, 2022
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic LeukemiaWenjian Yang, Seth E Karol, Keito Hoshitsuki, et al.
Pediatric Blood & Cancer|March 11, 2015
Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
Blood|August 9, 2023
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group studyBrent L Wood, Meenakshi Devidas, Ryan J Summers, et al.
Blood|July 10, 2010
Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexisDavid H McDermott, Suk See De Ravin, Hyun Sik Jun, et al.
Blood|January 5, 2023
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group reportNathan P Gossai, Meenakshi Devidas, Zhiguo Chen, et al.
Leukemia|April 15, 2018
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemiaMelissa A Burns, Zi Wei Liao, Natsuko Yamagata, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2012
Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupKimberly P Dunsmore, Meenakshi Devidas, Stephen B Linda, et al.
Biomarker Research|August 31, 2018
Dysregulated transcriptional networks in <i>KMT2A-</i> and <i>MLLT10</i>-rearranged T-ALLHuining Kang, Nitesh D Sharma, Christian K Nickl, et al.
Science Translational Medicine|May 18, 2012
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemiaDavid Wu, Anna Sherwood, Jonathan R Fromm, et al.
Blood Advances|July 23, 2021
Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphomaXinjie Xu, Christian N Paxton, Robert J Hayashi, et al.
JAMA Network Open|December 29, 2022
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic LeukemiaWenjian Yang, Seth E Karol, Keito Hoshitsuki, et al.
Pediatric Blood & Cancer|March 11, 2015
Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
Blood|August 9, 2023
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group studyBrent L Wood, Meenakshi Devidas, Ryan J Summers, et al.
Blood|July 10, 2010
Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexisDavid H McDermott, Suk See De Ravin, Hyun Sik Jun, et al.
Blood|January 5, 2023
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group reportNathan P Gossai, Meenakshi Devidas, Zhiguo Chen, et al.
Leukemia|April 15, 2018
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemiaMelissa A Burns, Zi Wei Liao, Natsuko Yamagata, et al.
Pageof 3